Novo Nordisk published the results on November 11 in the New England Journal of Medicine and announced them in a presentation at the American Heart Association meeting in Philadelphia on the same day
Jamie Bennett, a spokesperson for Wegovy and Ozempic maker Novo Nordisk, declined to comment on the concept of deprescription, noting that its drugs are intended for chronic conditions
Semaglutide and exercise can accelerate fat loss, preserve muscle, improve metabolism and insulin sensitivity, and boost energy, so pairing the right workouts with the proper meals and doses matters
With a thoughtful plan, many people find glutathione IV therapy becomes a valuable long-term tool in their wellness arsenal
However, its influence extends to the skin